By Gina Shaw
Washington state’s Medicaid provider must cover ledipasvir-sofosbuvir (Harvoni, Gilead) and other costly drugs for all patients with hepatitis C virus (HCV), not just those who are sickest, according to an order from a federal judge.
On May 27, U.S. District Judge John C. Coughenour granted a preliminary injunction that forces the state Health Care Authority (HCA) to end a 2015 policy restricting access to the drugs based on fibrosis score. Two Medicaid enrollees with